December 08
11:00 am - 12:00 pm EST

LOCAL TIME

DEL Kits Special Event: A New Method of Hit Discovery

Two years after initial launch, the next generation of DEL kits are ready for release. Self-service DNA-Encoded Library (DEL) kits are a core component of the Target-to-Hit platform at WuXi AppTec HitS. The updated DEL kits contain new features packed in one box: in line QC, online tracking, interactive reporting, and an AI enhanced hit finding option. DELopen is a freely accessible collection of DELs for academic drug-discovery, while DELight allows pharmaceutical companies to conduct a DEL screen in their own lab, without needing to reveal the identity of their target.

Who should attend
  • Academics interested in screening their (protein/biomolecule) targets for drug-like chemical matter using freely accessible DELs.
  • Industry scientists interested in conducting DEL screens without revealing target identity and/or developing proprietary screening techniques in their own labs.
What will be learned
  • Basics of how the DEL kits work
  • New features of the next generation of DEL kits
  • Success stories using DEL kits

register now
register for the webinar

Should you not be able to attend at the scheduled time, you will receive access to watch on-demand simply by registering for the event.

No cost to register, subject to confirmation.

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Alex Satz

Alex Satz

Senior Director DEL Strategy and Operations, WuXi AppTec

Alex Satz has 15+ years experience building DNA encoded library (DEL) platforms, and is currently the senior director of DEL strategy and operations at WuXi AppTec. Prior to WuXi AppTec, Alex led the Roche DEL platform in Basel Switzerland, and helped to develop the first industrial-scale DEL platform at Praecis Pharmaceuticals and GlaxoSmithKline.

Arsalan Arif
moderator

arsalan arif

Founder & Publisher, Endpoints News

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.